HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eric Voog Selected Research
Eric Voog Research Topics
Disease
10
Prostatic Neoplasms (Prostate Cancer)
01/2024 - 05/2005
8
Neoplasms (Cancer)
01/2023 - 02/2007
6
Neutropenia
12/2023 - 06/2003
4
Fatigue
12/2023 - 01/2020
4
Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 01/2020
4
Multiple Myeloma
01/2021 - 04/2004
3
Febrile Neutropenia
10/2023 - 05/2019
3
Carcinoma (Carcinomatosis)
01/2023 - 01/2015
2
Infections
10/2023 - 01/2018
2
Urinary Bladder Neoplasms (Bladder Cancer)
12/2021 - 01/2013
2
Disease Progression
01/2020 - 12/2018
2
Venous Thromboembolism
01/2019 - 02/2007
2
Thromboembolism
01/2019 - 02/2007
1
Anemia
12/2023
1
Sepsis (Septicemia)
10/2023
1
Urologic Neoplasms (Urological Cancer)
01/2023
1
Urinary Tract Infections (Urinary Tract Infection)
01/2022
1
Diarrhea
01/2022
1
Renal Insufficiency (Renal Failure)
12/2021
1
Hypertension (High Blood Pressure)
01/2020
1
Fever (Fevers)
06/2019
1
Thrombocytopenia 4
05/2019
1
Hemorrhage
01/2019
1
Thrombocytopenia (Thrombopenia)
01/2019
1
Lung Neoplasms (Lung Cancer)
10/2017
1
Pulmonary Embolism
02/2007
1
Thrombosis (Thrombus)
02/2007
1
Breast Neoplasms (Breast Cancer)
02/2007
1
Venous Thrombosis (Deep-Vein Thrombosis)
02/2007
1
Ovarian Neoplasms (Ovarian Cancer)
07/2004
Drug/Important Bio-Agent (IBA)
4
enzalutamide
IBA
01/2024 - 01/2023
4
Platinum
IBA
01/2023 - 07/2004
3
talazoparib
IBA
01/2024 - 01/2023
3
Androgen Receptors (Androgen Receptor)
IBA
12/2023 - 01/2023
3
Prostate-Specific Antigen (Semenogelase)
IBA
01/2023 - 05/2019
3
avelumab
IBA
01/2023 - 01/2020
3
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023 - 11/2020
3
rucaparib
IBA
01/2023 - 11/2020
3
Cisplatin (Platino)
FDA Link
Generic
12/2021 - 01/2013
3
Gemcitabine
FDA Link
01/2020 - 01/2013
2
taxane
IBA
10/2023 - 07/2004
2
Everolimus
FDA Link
12/2022 - 01/2020
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021 - 12/2018
2
Lenalidomide (CC 5013)
FDA Link
01/2021 - 01/2019
2
Hormones (Hormone)
IBA
05/2019 - 05/2005
2
Docetaxel (Taxotere)
FDA Link
05/2019 - 05/2005
2
Thalidomide (Thalomid)
FDA Link
01/2019 - 01/2017
2
Prednisone (Sone)
FDA Link
Generic
01/2017 - 05/2005
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2023
1
cabazitaxel
FDA Link
10/2023
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
10/2023
1
darolutamide
IBA
06/2023
1
A-Form DNA (A-DNA)
IBA
01/2023
1
insulin receptor-related receptor (IRR)
IBA
01/2023
1
serabelisib
IBA
12/2022
1
sapanisertib
IBA
12/2022
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2022
1
Immune Checkpoint Inhibitors
IBA
11/2021
1
ixazomib
IBA
01/2021
1
TOR Serine-Threonine Kinases
IBA
01/2020
1
Angiogenesis Inhibitors
IBA
01/2020
1
Carboplatin (JM8)
FDA Link
Generic
01/2020
1
cabozantinib
IBA
01/2020
1
Ligands
IBA
01/2020
1
Androgens
IBA
05/2019
1
Immunomodulating Agents
IBA
01/2019
1
apixaban
IBA
01/2019
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2018
1
pomalidomide
IBA
12/2018
1
Melphalan (Alkeran)
FDA Link
Generic
01/2017
1
Bortezomib (Velcade)
FDA Link
01/2017
1
Trastuzumab (Herceptin)
FDA Link
01/2015
1
Salts
IBA
01/2015
1
larotaxel
IBA
01/2013
1
Anticoagulants
IBA
02/2007
1
Hemostatics (Antihemorrhagics)
IBA
02/2007
1
Estramustine
FDA Link
05/2005
1
Mitoxantrone (Novantrone)
FDA Link
Generic
05/2005
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
05/2005
1
Tamoxifen
FDA Link
Generic
04/2004
1
Rituximab (Mabthera)
FDA Link
06/2003
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
10/2023 - 07/2004
7
Castration
01/2024 - 11/2020
7
Therapeutics
01/2023 - 12/2018
2
Immunotherapy
01/2022 - 01/2020
2
Catheters
01/2018 - 02/2007
2
Palliative Care (Palliative Therapy)
10/2017 - 05/2005
1
Drug Tapering
01/2023
1
Combination Drug Therapy (Combination Chemotherapy)
12/2021
1
Stem Cell Transplantation
01/2017
1
Central Venous Catheters
02/2007
1
Adjuvant Chemotherapy
07/2004